Kepler Capital analyst Christophe dombu maintained a Buy rating on MaaT Pharma (MAAT – Research Report) on March 12 and set a price target of ...
French clinical-stage biotechnology and microbiome therapy company MaaT Pharma has seen success with its Phase III trial of MaaT013 meeting its primary endpoints, leading to a jump in the company ...
DelveInsight estimates approximately 52K cases of Graft Versus Host Disease in the 7MM. In 2023, the EU4 and the UK recorded ...
MaaT Pharma Receives Positive Opinion from EMA Pediatric Committee on the Pediatric Investigation Plan for MaaT013.
MaaT Pharma’s quest to bring a microbiota-based therapy to market has moved a step forward with new data showing a benefit for its MaaT013 candidate in an early-access programme (EAP).
EXCLUSIVE: Strig Artist Management is bolstering its team, bringing on Christina Montojo as Manager and promoting Maat Bates from Assistant to Coordinator. Montojo moves to Strig Artist Management ...
Bates began working at Strig Artist Management as an assistant in May 2024. Upon moving to Los Angeles, Bates started her career as a producing fellow at The Music Center. This sparked her ...